Oxidative stress-induced expression and modulation of Phosphatase of Regenerating Liver-1 (PRL-1) in mammalian retina

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 9, 2007, Pages 1473-1482

  Yu, Ling ^a   Kelly, Una ^a   Ebright, Jessica N ^a   Malek, Goldis ^a   Saloupis, Peter ^a   Rickman, Dennis W ^a   McKay, Brian S ^b   Arshavsky, Vadim Y ^a   Bowes Rickman, Catherine ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cysteine; Light damage; Oxidation reduction; Phosphatase; Photoreceptor; Retina

Indexed keywords

CYCLOHEXIMIDE; CYSTEINE; GLUTATHIONE; HYDROGEN PEROXIDE; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DISULFIDE BOND; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME REGULATION; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOCALIZATION; LIGHT DAMAGE; LIGHT EXPOSURE; NUCLEOTIDE SEQUENCE; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHOTOOXIDATION; PHOTORECEPTOR; PRIORITY JOURNAL; PRL 1 GENE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA; RETINA CONE; RETINA FOVEA;

ANIMALS; CATALYTIC DOMAIN; CELL CYCLE PROTEINS; CELL LINE; CELLS, CULTURED; CONES (RETINA); CYCLOHEXIMIDE; CYSTEINE; DITHIOTHREITOL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; HYDROGEN PEROXIDE; IMMEDIATE-EARLY PROTEINS; MEMBRANE PROTEINS; MICE; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN SYNTHESIS INHIBITORS; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; REDUCING AGENTS; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE;

MAMMALIA; PRIMATES; RATTUS;

EID: 34548498188     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.06.005     Document Type: Article

References (59)

1. Yarovinsky T.O., Rickman D.W., Diamond R.H., Taub R., Hageman G.S., and Bowes Rickman C. Expression of the protein tyrosine phosphatase, phosphatase of regenerating liver 1, in the outer segments of primate cone photoreceptors. Brain Res. Mol. Brain Res. 77 (2000) 95-103
2. Peng Y., Genin A., Spinner N.B., Diamond R.H., and Taub R. The gene encoding human nuclear protein tyrosine phosphatase, PRL-1. Cloning, chromosomal localization, and identification of an intron enhancer. J. Biol. Chem. 273 (1998) 17286-17295
3. Gehrig A., Felbor U., Kelsell R.E., Hunt D.M., Maumenee I.H., and Weber B.H. Assessment of the interphotoreceptor matrix proteoglycan-1 (IMPG1) gene localised to 6q13-q15 in autosomal dominant Stargardt-like disease (ADSTGD), progressive bifocal chorioretinal atrophy (PBCRA), and North Carolina macular dystrophy (MCDR1). J. Med. Genet. 35 (1998) 641-645
4. Diamond R.H., Cressman D.E., Laz T.M., Abrams C.S., and Taub R. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol. Cell. Biol. 14 (1994) 3752-3762
5. Zeng Q., Hong W., and Tan Y.H. Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochem. Biophys. Res. Commun. 244 (1998) 421-427
6. Bardelli A., Saha S., Sager J.A., Romans K.E., Xin B., Markowitz S.D., Lengauer C., Velculescu V.E., Kinzler K.W., and Vogelstein B. PRL-3 expression in metastatic cancers. Clin. Cancer Res. 9 (2003) 5607-5615
7. Cates C.A., Michael R.L., Stayrook K.R., Harvey K.A., Burke Y.D., Randall S.K., Crowell P.L., and Crowell D.N. Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases. Cancer Lett. 110 (1996) 49-55
8. Zeng Q., Si X., Horstmann H., Xu Y., Hong W., and Pallen C.J. Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome. J. Biol. Chem. 275 (2000) 21444-21452
9. Kozlov G., Cheng J., Ziomek E., Banville D., Gehring K., and Ekiel I. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3. J. Biol. Chem. 279 (2004) 11882-11889
10. Jeong D.G., Kim S.J., Kim J.H., Son J.H., Park M.R., Lim S.M., Yoon T.S., and Ryu S.E. Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms. J. Mol. Biol. 345 (2005) 401-413
11. Maehama T., and Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273 (1998) 13375-13378
12. Diamond R.H., Cressman D.E., Laz T.M., Abrams C.S., and Taub R. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol. Cell. Biol. 14 (1994) 3752-3762
13. Takano S., Fukuyama H., Fukumoto M., Kimura J., Xue J.H., Ohashi H., and Fujita J. PRL-1, a protein tyrosine phosphatase, is expressed in neurons and oligodendrocytes in the brain and induced in the cerebral cortex following transient forebrain ischemia. Brain Res. Mol. Brain Res. 40 (1996) 105-115
14. Diamond R.H., Peters C., Jung S.P., Greenbaum L.E., Haber B.A., Silberg D.G., Traber P.G., and Taub R. Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine. Am. J. Physiol. 271 (1996) G121-G129
15. Carter D.A. Expression of a novel rat protein tyrosine phosphatase gene. Biochim. Biophys. Acta 1442 (1998) 405-408
16. Rundle C.H., and Kappen C. Developmental expression of the murine Prl-1 protein tyrosine phosphatase gene. J. Exp. Zool. 283 (1999) 612-617
17. Wang J., Kirby C.E., and Herbst R. The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis. J. Biol. Chem. 277 (2002) 46659-46668
18. Peters C.S., Liang X., Li S., Kannan S., Peng Y., Taub R., and Diamond R.H. ATF-7, a novel bZIP protein, interacts with the PRL-1 protein-tyrosine phosphatase. J. Biol. Chem. 276 (2001) 13718-13726
19. Kessler-Becker D., Krieg T., and Eckes B. Expression of pro-inflammatory markers by human dermal fibroblasts in a three-dimensional culture model is mediated by an autocrine interleukin-1 loop. Biochem. J. 379 (2004) 351-358
20. Daoud S.S., Munson P.J., Reinhold W., Young L., Prabhu V.V., Yu Q., LaRose J., Kohn K.W., Weinstein J.N., and Pommier Y. Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study. Cancer Res. 63 (2003) 2782-2793
21. Peng Y., Du K., Ramirez S., Diamond R.H., and Taub R. Mitogenic up-regulation of the PRL-1 protein-tyrosine phosphatase gene by Egr-1. Egr-1 activation is an early event in liver regeneration. J. Biol. Chem. 274 (1999) 4513-4520
22. Cho S.H., Lee C.H., Ahn Y., Kim H., Kim H., Ahn C.Y., Yang K.S., and Lee S.R. Redox regulation of PTEN and protein tyrosine phosphatases in H(2)O(2) mediated cell signaling. FEBS Lett. 560 (2004) 7-13
23. den Hertog J., Groen A., and van der Wijk T. Redox regulation of protein-tyrosine phosphatases. Arch. Biochem. Biophys. 434 (2005) 11-15
24. Forman H.J., Fukuto J.M., and Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am. J. Physiol.: Cell Physiol. 287 (2004) C246-C256
25. Meng T.C., Fukada T., and Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9 (2002) 387-399
26. Rudolph J. Catalytic mechanism of Cdc25. Biochemistry 41 (2002) 14613-14623
27. Salmeen A., Andersen J.N., Myers M.P., Meng T.C., Hinks J.A., Tonks N.K., and Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423 (2003) 769-773
28. Groen A., Lemeer S., van der Wijk T., Overvoorde J., Heck A.J., Ostman A., Barford D., Slijper M., and den Hertog J. Differential oxidation of protein-tyrosine phosphatases. J. Biol. Chem. 280 (2005) 10298-10304
29. Winkler B.S., Boulton M.E., Gottsch J.D., and Sternberg P. Oxidative damage and age-related macular degeneration. Mol. Vis. 5 (1999) 32
30. Cideciyan A.V., Zhao X., Nielsen L., Khani S.C., Jacobson S.G., and Palczewski K. Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 328-333
31. Tomany S.C., Cruickshanks K.J., Klein R., Klein B.E., and Knudtson M.D. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch. Ophthalmol. 122 (2004) 750-757
32. Nakamura H., Nakamura K., and Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15 (1997) 351-369
33. Thompson C.L., Rickman C.B., Shaw S.J., Ebright J.N., Kelly U., Sancar A., and Rickman D.W. Expression of the blue-light receptor cryptochrome in the human retina. Invest. Ophthalmol. Visual Sci. 44 (2003) 4515-4521
34. Sun J.P., Wang W.Q., Yang H., Liu S., Liang F., Fedorov A.A., Almo S.C., and Zhang Z.Y. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion(,). Biochemistry 44 (2005) 12009-12021
35. Welte S., Baringhaus K.H., Schmider W., Muller G., Petry S., and Tennagels N. 6,8-Difluoro-4-methylumbiliferyl phosphate: a fluorogenic substrate for protein tyrosine phosphatases. Anal. Biochem. 338 (2005) 32-38
36. Georgescu M.M., Kirsch K.H., Akagi T., Shishido T., and Hanafusa H. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10182-10187
37. Sohn J., and Rudolph J. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. Biochemistry 42 (2003) 10060-10070
38. Tan E., Ding X.Q., Saadi A., Agarwal N., Naash M.I., and Al-Ubaidi M.R. Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest. Ophthalmol. Visual Sci. 45 (2004) 764-768
39. Lee S.R., Yang K.S., Kwon J., Lee C., Jeong W., and Rhee S.G. Reversible inactivation of the tumor suppressor PTEN by H2O2. J. Biol. Chem. 277 (2002) 20336-20342
40. Jahngen-Hodge J., Obin M.S., Gong X., Shang F., Nowell Jr. T.R., Gong J., Abasi H., Blumberg J., and Taylor A. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J. Biol. Chem. 272 (1997) 28218-28226
41. Ebright J.N., and Bowes Rickman C. Rapid, reproducible Real-Time Quantitative RT-PCR using the iCycler iQ Real-Time PCR Detection System and iQ Supermix. BioRadiations 110 (2003) 32-35
42. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) (RESEARCH0034)
43. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
44. Zhang Z.Y. Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis. Crit. Rev. Biochem. Mol. Biol. 33 (1998) 1-52
45. Denu J.M., and Dixon J.E. Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr. Opin. Chem. Biol. 2 (1998) 633-641
46. Denu J.M., Stuckey J.A., Saper M.A., and Dixon J.E. Form and function in protein dephosphorylation. Cell 87 (1996) 361-364
47. Barford D., Flint A.J., and Tonks N.K. Crystal structure of human protein tyrosine phosphatase 1B. Science 263 (1994) 1397-1404
48. Denu J.M., and Tanner K.G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37 (1998) 5633-5642
49. LaVail M.M., Unoki K., Yasumura D., Matthes M.T., Yancopoulos G.D., and Steinberg R.H. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 11249-11253
50. Tanito M., Nishiyama A., Tanaka T., Masutani H., Nakamura H., Yodoi J., and Ohira A. Change of redox status and modulation by thiol replenishment in retinal photooxidative damage. Invest. Ophthalmol. Visual Sci. 43 (2002) 2392-2400
51. 2. J. Biol. Chem. 273 (1998) 32554-32560
52. Claiborne A., Miller H., Parsonage D., and Ross R.P. Protein-sulfenic acid stabilization and function in enzyme catalysis and gene regulation. FASEB J. 7 (1993) 1483-1490
53. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
54. Chiarugi P., Fiaschi T., Taddei M.L., Talini D., Giannoni E., Raugei G., and Ramponi G. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J. Biol. Chem. 276 (2001) 33478-33487
55. Beatty S., Koh H., Phil M., Henson D., and Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45 (2000) 115-134
56. Provis J.M., Penfold P.L., Cornish E.E., Sandercoe T.M., and Madigan M.C. Anatomy and development of the macula: specialisation and the vulnerability to macular degeneration. Clin. Exp. Optom. 88 (2005) 269-281
57. Penn J.S., Naash M.I., and Anderson R.E. Effect of light history on retinal antioxidants and light damage susceptibility in the rat. Exp. Eye Res. 44 (1987) 779-788
58. Wenzel A., Grimm C., Marti A., Kueng-Hitz N., Hafezi F., Niemeyer G., and Reme C.E. c-fos controls the "private pathway" of light-induced apoptosis of retinal photoreceptors. J. Neurosci. 20 (2000) 81-88
59. Gao X., and Talalay P. Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10446-10451